Cantharidin
규격
56-25-7CAS 번호
200-263-3EC 번호
(1S,2R,6S,7R)-2,6-dimethyl-4,10-dioxatricyclo[5.2.1.02,6]decane-3,5-dioneIUPAC 명칭
C10H12O4화학식
196.2 g/mol분자량
cantharidin; Cantharone; CANTHARIDINE; 56-25-7; Cantharides camphor; Kantaridin; Kantharidin; Cantaridina; Cantharidinum; 1,2-Dimethyl-3,6-epoxyperhydrophthalic anhydride; exo-1,2-cis-Dimethyl-3,6-epoxyhexahydrophthalic anhydride; (3ar,4s,7r,7as)-3a,7a-dimethylhexahydro-4,7-epoxy-2-benzofuran-1,3-dione; IGL471WQ8P; NSC-61805; YCANTH; 2,3-Dimethyl-7-oxabicyclo(2.2.1)heptane-2,3-dicarboxylic anhydride; CHEBI:64213; 7-Oxabicyclo(2.2.1)heptane-2,3-dicarboxylic anhydride, 2,3-dimethyl-; Hexahydro-3aalpha,7aalpha-dimethyl-4beta,7beta-epoxyisobenzofuran-1,3-dione; (1S,2R,6S,7R)-2,6-dimethyl-4,10-dioxatricyclo(5.2.1.02,6)decane-3,5-dione; (1S,2R,6S,7R)-2,6-dimethyl-4,10-dioxatricyclo[5.2.1.02,6]decane-3,5-dione; RefChem:123249; CANTHARIDIN 0.7%; DTXCID601764425; 200-263-3; 4,7-Epoxyisobenzofuran-1,3-dione, hexahydro-3a,7a-dimethyl-, (3aalpha,4beta,7beta,7aalpha)-; DTXSID7041752; Cantharidin [USAN]; NSC61805; 4,7-Epoxyisobenzofuran-1,3-dione, hexahydro-3a,7a-dimethyl-, (3aR,4S,7R,7aS)-rel-; MFCD00134968; CHEMBL48449; CAN [Alkaloid]; NSC 61805; Kantharidin [German]; Caswell No. 157; CCRIS 635; HSDB 2181; AI3-04021; EINECS 200-263-3; UNII-IGL471WQ8P; EPA Pesticide Chemical Code 013101; 3a,7a-Dimethylhexahydro-4,7-epoxyisobenzofuran-1,3-dione; BRN 0085302; CAS-56-25-7; NCGC00016247-01; Ycanth (TN); CANTHARIDIN [MI]; Prestwick3_000885; CANTHARIDIN [INN]; Cantharidin (JAN/USAN); CANTHARIDIN [IARC]; (1R,2S,3R,6S)-1,2-Dimethyl-3,6-epoxycyclohexane-1,2-dicarboxylic anhydride; 2,3-dicarboxylic anhydride; 7a-Dimethylhexahydro-3a,4,7-epoxyisobenzofuran; CANTHARIDIN [VANDF]; CANTHARIDINE [HSDB]; NCIMech_000301; CANTHARIDIN [MART.]; CANTHARIDINUM [HPUS]; BSPBio_000670; CANTHARIDIN [WHO-DD]; 4,7-Epoxyisobenzofuran-1,3-dione, hexahydro-3a,7a-dimethyl-, (3a-alpha,4-beta,7-beta,7a-alpha); 5-19-05-00051 (Beilstein Handbook Reference); orb421994; SCHEMBL152262; BPBio1_000738; orb2893612; orb3139388; SCHEMBL31628232; cid_6708701; GTPL13081; HMS2097B12; HMS3412J13; HMS3676J13; 1,6-epoxyperhydrophthalic anhydride; 4,7-Epoxyisobenzofuran-1,3-dione, hexahydro-3a,7a-dimethyl-, (3a.alpha.,4.beta.,7.beta.,7a.alpha.)-; HY-N0209; MSK40063; BDBM50090505; CCG-35382; CCG-36082; EBC-26179; WHO 11470; AKOS015895930; AC-7967; CS-4979; DB12328; FC29633; (1R,2S,6R,7S)-2,6-dimethyl-4,10-dioxatricyclo[5.2.1.02,6]decane-3,5-dione; 4,3-dione, hexahydro-3a,7a-dimethyl-; exo-1,6-epoxyhexahydrophthalic anhydride; NCGC00025212-02; NCGC00025212-03; NCGC00025212-04; NCGC00025212-05; NCGC00025212-09; NCGC00025212-31; AS-18735; NCI60_005413; VP-102 drug/device delivering cantharidin; WLN: T C555 A AO DVOVTJ C1 G1; AB00513946; Hexahydro-3a,7-epoxyisobenzofuran-1,3-dione; D11745; 7-Oxabicyclo[2.2.1]heptane-2, 2,3-dimethyl-; EN300-24727854; Q410884; SR-01000597585; SR-01000597585-1; BRD-K80684056-001-01-0; BRD-K80684056-001-04-4; BRD-K80684056-001-05-1; BRD-K80684056-001-06-9; Ycanth (0.7% solution, single-use topical applicator); 3alpha,7alpha-Dimethylhexahydro-4,7-epoxyisobenzofuran-1,3-dione; (3aR,4S,7R,7aS)-3a,7a-dimethylhexahydro-4,7-epoxyisobenzofuran-1,3-dione; (1R,2S,6R,7S)-2,6-Dimethyl-4,10-dioxa-tricyclo[5.2.1.0*2,6*]decane-3,5-dione; (1R,2S,6R,7S)-2,6-dimethyl-4,10-dioxatricyclo[5.2.1.0,2,6]decane-3,5-dione; (1R,5S,6R,9S)-rel-1,5-Dimethyl-3,10-dioxatricyclo[3.2.1.01,5]decane-2,4-dione; (1R,7S)-2,6-Dimethyl-4,10-dioxa-tricyclo[5.2.1.0*2,6*]decane-3,5-dione; (1S,2R,6S,7R)-2,6-Dimethyl-4,10-dioxa-tricyclo[5.2.1.0*2,6*]decane-3,5-dione; (1S,3S,4R,7R)-2,6-dimethyl-4,10-dioxa-tricyclo[5.2.1.0-2,6]decane-3,5-dione; 4,3-dione, hexahydro-3a,7a-dimethyl-, (3a.alpha.,4.beta.,7.beta.,7a.alpha.)-; HEXAHYDRO-3A.ALPHA.,7A.ALPHA.-DIMETHYL-4.BETA.,7.BETA.-EPOXYISOBENZOFURAN-1,3-DIONE동의어
